CF
COASTAL FINANCIAL CORP (CCB)·Q4 2024 Earnings Summary
Executive Summary
- Q4 revenue was $143.3M, down 5.9% q/q, while diluted EPS was $0.94 (vs. $0.97 in Q3) but up 42% y/y from $0.66; net income was $13.4M (flat q/q) .
- Net interest income fell 7.9% q/q to $66.5M as CCB sold $845.5M of loans (mostly credit card receivables), the Fed’s December cut reduced yields, and more loans were moved to nonaccrual; NIM declined to 6.65% .
- Deposit costs fell to 3.21% from 3.59% q/q; NIM net of BaaS loan expense improved to 4.16% (from 4.06%), indicating underlying spread health despite headline NIM compression .
- Capital raised: $98.0M common equity at $71/share lifted Company CET1 to 12.04% and Total RBC to 14.67%, positioning for growth (esp. in CCBX) .
- CCBX program fee income rose 27.6% q/q to $8.2M; management will keep selling credit card loans while retaining fee income and expects slight NIM expansion as deposit costs reprice faster than loan yields .
What Went Well and What Went Wrong
What Went Well
- CCBX fee monetization accelerated: program fees reached $8.2M, +27.6% q/q, and +56.9% for FY24; CEO: “We continue to invest heavily in CCBX... we are pleased to have three letters of intent signed going into 2025 with an active pipeline.” .
- Funding costs improved: consolidated cost of deposits fell to 3.21% (from 3.59% q/q), with community bank deposit costs at 1.86% (down from 1.92%) .
- Balance sheet strength: completed $98.0M equity raise; Company CET1 rose to 12.04%, Total capital to 14.67%, supporting growth and risk absorption .
What Went Wrong
- Spread pressure: net interest income decreased 7.9% q/q to $66.5M and NIM fell to 6.65% as loan sales, a Fed cut, and broader nonaccrual designation weighed on asset yields .
- Credit costs remain elevated in CCBX: provision was $61.9M (vs. $70.3M in Q3); net charge-offs were $55.9M in the quarter; note most CCBX losses are indemnified by partners (see below) .
- BaaS fraud expense rose by $3.0M q/q, partially offsetting declines in BaaS loan expense; legal and professional fees also increased with risk/infrastructure investment .
Financial Results
Note: CCB cites 182,449 credit cards with fee-earning potential as of 12/31/24 (+101,023 q/q; +172,400 y/y); the prior period levels are disclosed as deltas rather than an explicit Q4’23 count .
Guidance Changes
No numerical revenue/EPS/OpEx/tax guidance was provided in company materials reviewed.
Earnings Call Themes & Trends
Management Commentary
- “2024 was highlighted by the completion of our $98.0 million capital raise during the fourth quarter, which we will utilize to support growth of the Bank including in our CCBX segment.” — CEO Eric Sprink .
- “As we look forward to 2025, our strategy involves selectively expanding our current base of CCBX partners while continuing to invest in and enhance our technology and risk management infrastructure… We plan to continue selling credit card loans while retaining a portion of the fee income… to provide a more stable income stream in the future.” — CEO Eric Sprink .
Q&A Highlights
- An earnings call transcript for Q4 2024 was not available in our document search; therefore, Q&A highlights and any on-call guidance clarifications are unavailable.
Estimates Context
- Wall Street consensus estimates (S&P Global) were unavailable at the time of this analysis due to access limits. As a result, we cannot present a formal beat/miss versus consensus for revenue or EPS this quarter.
Key Takeaways for Investors
- Spread normalization underway: headline NIM declined with loan sales and yield headwinds, but NIM net of BaaS expense improved and deposit costs fell, pointing to underlying spread stabilization/improvement into 2025 .
- Capital to grow CCBX: $98M equity raise boosted CET1 to 12.04%, enabling partner/product expansion while managing concentration and credit limits .
- Fee-income flywheel: CCBX program fees rose 27.6% q/q to $8.2M, and management will continue to sell credit card loans while retaining fee income, diversifying revenue away from rate sensitivity .
- Credit risk elevated but largely indemnified: net charge-offs remain high in CCBX, but ~98% are reimbursed by partners; ACL coverage is strong (CCBX ACL 9.86% of CCBX loans) .
- Cost discipline vs. growth investments: noninterest expense declined q/q with lower BaaS loan expense, though fraud expense and legal/tech spend rose to support risk systems at scale .
- Tactical catalysts: further deposit cost declines from the December cut, additional loan sales with fee retention, and conversion of three LOIs in CCBX could lift core earnings momentum and narrative around fee-based growth .